- Tigem Research Highlights
-
Low-dose gene therapy reduces the frequency of enzyme replacement therapy in a mouse model of lysosomal storage disease
-
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
-
Brain Targeting in MPS-IIIA
- Our Vision
-
TIGEM (Telethon Institute of Genetics and Medicine) is an international research institute dedicated to the discovery of the mechanisms underlying rare genetic diseases and the development of innovative therapies. Learn more >>
- Upcoming Seminars and Events
-
Jennifer Lippincott-Schwartz - "Emerging fluorescence technology to study cell architecture and dynamics" (Group Leader, Howard Hughes Medical Institute - Janelia Research Campus, Ashburn, VA, USA) Oct 21, 2016
-
Prof. Howard Reizman -"New technologies to study lipid homeostasis and function" (Department of Biochemistry, University of Geneva, Geneva, Switzerland) Oct 25, 2016
- PHD Programs - Call now closed
-
PHD Programs
Tigem offers two PhD programs for talented students wishing to pursue a career in research or education. Learn more >>
